Cargando…

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

Among the unknowns in decoding the pathogenesis of SARS-CoV-2 persistent symptoms in Long Covid is whether there is a contributory role of abnormal immunity during acute infection. It has been proposed that Long Covid is a consequence of either an excessive or inadequate initial immune response. Her...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altmann, Daniel M., Reynolds, Catherine J., Joy, George, Otter, Ashley D., Gibbons, Joseph M., Pade, Corinna, Swadling, Leo, Maini, Mala K., Brooks, Tim, Semper, Amanda, McKnight, Áine, Noursadeghi, Mahdad, Manisty, Charlotte, Treibel, Thomas A., Moon, James C., Boyton, Rosemary J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447583/ https://www.ncbi.nlm.nih.gov/pubmed/37612310 http://dx.doi.org/10.1038/s41467-023-40460-1

Ejemplares similares

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
por: Manisty, Charlotte, et al.
Publicado: (2021)

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
por: Reynolds, Catherine J., et al.
Publicado: (2021)

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response
por: Doykov, Ivan, et al.
Publicado: (2022)

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
por: Reynolds, Catherine J., et al.
Publicado: (2022)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection
por: Manisty, Charlotte, et al.
Publicado: (2021)

Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections
por: Chandran, Aneesh, et al.
Publicado: (2022)

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19
por: Astbury, Stuart, et al.
Publicado: (2022)

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection
por: Milighetti, Martina, et al.
Publicado: (2023)

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
por: Reynolds, Catherine J., et al.
Publicado: (2020)

Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
por: Gupta, Rishi K, et al.
Publicado: (2021)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply
por: Treibel, Thomas A, et al.
Publicado: (2020)

COVID-19: PCR screening of asymptomatic health-care workers at London hospital
por: Treibel, Thomas A, et al.
Publicado: (2020)

COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
por: Milojkovic, Dragana, et al.
Publicado: (2022)

Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk.
por: Valdes, Ana M., et al.
Publicado: (2021)

Curbside particulate matter and susceptibility to SARS–CoV-2 infection
por: Miyashita, Lisa, et al.
Publicado: (2023)

Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
por: Swadling, Leo, et al.
Publicado: (2023)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly, et al.
Publicado: (2013)

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19
por: Usai, Carla, et al.
Publicado: (2022)

Novel restriction factor RNA-associated early-stage anti-viral factor (REAF) inhibits human and simian immunodeficiency viruses
por: Marno, Kelly M, et al.
Publicado: (2014)

Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
por: Reynolds, Catherine J., et al.
Publicado: (2022)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

Clinical academic research in the time of Corona: A simulation study in England and a call for action
por: Banerjee, Amitava, et al.
Publicado: (2020)

The past, current and future epidemiological dynamic of SARS-CoV-2
por: Balloux, François, et al.
Publicado: (2022)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial
por: Jolliffe, David A., et al.
Publicado: (2022)

Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
por: Diniz, Mariana O., et al.
Publicado: (2022)

Immunopathogenesis of Severe Sepsis
por: Noursadeghi, Mahdad, et al.
Publicado: (2000)

Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
por: McDonald, Ian, et al.
Publicado: (2021)

Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers
por: Joy, George, et al.
Publicado: (2021)

What policy makers need to know about COVID-19 protective immunity
por: Altmann, Daniel M, et al.
Publicado: (2020)

Interactions between HIV-1 and the Cell-Autonomous Innate Immune System
por: Towers, Greg J., et al.
Publicado: (2014)

Does tuberculosis threaten our ageing populations?
por: Byng-Maddick, Rachel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4b39jqhva6kfjq7e25s6il619i